Modern formulations have evolved to improve not just ingredient quality but also delivery and stability
It is known that ALA can accelerate the initial repigmentation response
There is only 1 previous report of the appearance of large erythematous edematous plaques in the areas of injection of lipolytic substances, similar to those observed in our patient.10 The injection of excessive quantities of substances with a lipolytic effect, poor circulation, previous scarring in the area treated, or a poor injection technique that leaves the bolus too superficial, are possible causes of the appearance of this complication
Still, the benefits of treating deficiency usually outweigh the increased chance of bruising
(Hurley & Frier, 2025) For patients, this means the first question to ask of any provider offering peptide therapy isn't "do you offer peptides" but "how are you sourcing them and what is the current regulatory status of each compound you prescribe?" A provider still listing Category 2 compounds as standard menu offerings without discussing compounding compliance is telling you something important about their regulatory literacy
